NL-OMON22511尚未招募不适用
A phase II study of ARA 290 as therapeutic strategy in rheumatoid arthritis.
eiden University Medical Center0 个研究点目标入组 14 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 14
研究概览
简要总结
Brines M, Cerami A. Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. Kidney Int 2006; 70(2):246-50.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Diagnosis of RA, classified by ARA (American Rheumatism Association) 1987 revised criteria;
- •2. Active disease at screening and baseline: 6/68 tender and 6/66 swollen joints and either an erythrocyte sedimentation rate (ESR) of >=28 mm/hr or C-reactive protein (CRP)> 10 mg/l;
排除标准
- •1. Current or previous treatment with biological agent;
- •2. Clinically relevant abnormal laboratory results, ECG, vital signs, or physical findings other than conditions related to rheumatoid arthritis (as judged by the investigator);
研究者
相似试验
Unknown
2 期
ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)Diabetes Type 2Impaired Glucose ToleranceImpaired Fasting GlucoseNCT01933529Claes-Göran Östenson24
进行中（未招募）
1 期
A study of the safety and ability of ARA 290 administered subcutaneously improving blood sugar control in people with prediabetesMedDRA version: 17.0Level: LLTClassification code 10065542Term: PrediabetesSystem Organ Class: 100000004861For the complementary visitsup to 12 Subjects with Prediabetes (impaired fasting glucose, impaired glucose tolerance) or diet-treated type 2 diabetes, will be chosen from the currently approved clinical protocol.MedDRA version: 17.0Level: LLTClassification code 10012613Term: Diabetes mellitus non-insulin-dependentSystem Organ Class: 100000004861EUCTR2012-003207-35-SEKarolinska University Hospital Solna12
已完成
2 期
A Study of the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood)Blood TransfusionOrthopedic ProceduresAnemiaNCT00270114Johnson & Johnson Pharmaceutical Research & Development, L.L.C.55
已完成
2 期
Erythropoietin for Management of Anemia Caused by ChemotherapyDiffuse Large B-cell LymphomaNCT02890602Kosin University Gospel Hospital53
招募中
不适用
Erythropoietin therapy for children with cerebral palsyDiseases of the nervous systemKCT0000482Bundang CHA General Hospital10